drugset / Trial / NCT06297967

Acetic Acid 2% Solution for Skin Ulcers

NCT06297967

Phase 3 Recruiting 104 enrolled Consorci Sanitari de l'Alt Penedès i Garraf
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this clinical trial is to assess the effectiveness of acetic acid in patients suffering from chronic cutaneous ulcers with biofilm. The primary question it seeks to address is whether acetic acid (as a 2% topical solution) is superior to the current standard treatment for chronic cutaneous ulcers with biofilm at our center (Prontosan®). Participants will be randomly assigned to receive either the acetic acid solution treatment or the standard current treatment.

Timeline

Start
2025-04-27
Primary completion
2027-03
Completion
2027-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetic Acid Diagnostic / imaging agent 2 % Topical
Comparator Prontosan Other / unclassified Topical

Indications